Stockreport

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF 2025 was a year of tenacity, strategic transactions and building traction for RedHillTalicia® business transformed:Formation of Talicia Holdings Inc. (THI) and the U.S. [Read more]